Abstract |
Increasing interest in the potent anti- tuberculosis activity and the novel target (QcrB) of imidazo[1,2-a] pyridine-3-carboxamides encouraged extended structure-activity relationship studies of additional scaffolds. This study reports on the in vitro profiling of the imidazo[2,1-b] thiazole-5-carboxamides as a new promising class of anti- tuberculosis compounds endowed with nanomolar potency against replicating and drug-resistant Mycobacterium tuberculosis (Mtb) as well as low toxicity to VERO cells. Compounds 6, 16, and 17 had MIC values <10 nM and toxicity >100 μM. On-target selectivity of this series was confirmed by cross-resistance of specific QcrB mutants as well as the hypersusceptibility of a mutant with a functional gene deletion of the alternative cytochrome bd oxidase. Additionally, to demonstrate selectivity, three analogues (6, 15, 17) were broadly screened against a diverse set of eight strains of bacteria, including both Gram-positive and Gram-negative as well as six disease-causing non- tuberculosis mycobacteria. Finally, compounds 16 and 17 were found to be active in macrophages infected with Mtb.
|
Authors | Garrett C Moraski, Natalie Seeger, Patricia A Miller, Allen G Oliver, Helena I Boshoff, Sanghyun Cho, Surafel Mulugeta, Jeffery R Anderson, Scott G Franzblau, Marvin J Miller |
Journal | ACS infectious diseases
(ACS Infect Dis)
Vol. 2
Issue 6
Pg. 393-8
(06 10 2016)
ISSN: 2373-8227 [Electronic] United States |
PMID | 27627627
(Publication Type: Journal Article)
|
Chemical References |
- Antitubercular Agents
- Imidazoles
- Thiazoles
|
Topics |
- Animals
- Antitubercular Agents
(chemical synthesis, chemistry, pharmacology)
- Chlorocebus aethiops
- Humans
- Imidazoles
(chemistry)
- Molecular Structure
- Mycobacterium tuberculosis
(drug effects, genetics, physiology)
- Structure-Activity Relationship
- Thiazoles
(chemistry)
- Tuberculosis
(drug therapy, microbiology)
- Vero Cells
|